Cytosorbents Corporation (CTSO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -1.16M | -4.83M | -2.58M | -1.51M | -3.46M | -2.34M | -2.46M | -4.79M | -4.83M | -6.41M | -5.21M | -6.93M | -3.11M | -5.34M | -6.73M | -8.04M | -8.12M | -5.49M | -4.13M | -2.04M |
| Operating CF Margin % | -13.11% | -52.25% | -27.17% | -15.7% | -39.7% | -25.6% | -28.58% | -54.23% | -53.73% | -87.19% | -67.14% | -73.6% | -32.89% | -56.87% | -104.21% | -94.64% | -102.46% | -50.93% | -46.43% | -17.92% |
| Operating CF Growth % | 66.46% | -106.01% | -4.7% | 68.51% | 28.26% | 63.45% | 52.73% | 30.85% | -55.39% | -19.98% | 22.7% | 13.76% | 61.72% | 2.75% | -62.93% | -294.84% | -246.35% | -419.15% | -25.86% | -205.06% |
| Net Income | -5.13M | -5.5M | -3.17M | 1.95M | -1.48M | -7.88M | -2.33M | -4.14M | -6.09M | -5.83M | -9.19M | -6.15M | -7.33M | -766.13K | -12.2M | -10.88M | -8.97M | -9.31M | -6.41M | -4.68M |
| Depreciation & Amortization | 376K | -291K | 401K | 440.25K | 404.75K | 425.63K | 428.77K | 446.51K | 443.21K | 792.67K | 462.65K | 457.4K | 314.07K | 278.65K | 277.6K | 293.29K | 282.09K | 612.44K | 237.1K | 123.75K |
| Stock-Based Compensation | 0 | 1.46M | 488K | 0 | 818.43K | 1.51M | 486.51K | 837.58K | 959.47K | 1.05M | 1.35M | 214.54K | 1.08M | 1.1M | 1.38M | 0 | 946.48K | 1.1M | 1.36M | 2.63M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.3M | 1.99M | -231.9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.34M | 669.07K | 438K | -5.15M | -2.82M | 5.12M | -2.32M | 830.16K | 1.53M | -194.81K | 10.71K | 10.71K | -526.86K | -4.2M | 3.22M | 3.04M | 1.53M | 486.84K | 996.5K | -231.16K |
| Working Capital Changes | 1.25M | -1.17M | -734K | 1.26M | -388.04K | -1.52M | 1.28M | -2.77M | -1.67M | 74.3K | 167.74K | -1.23M | 3.35M | -1.75M | 591.33K | -496.61K | -1.91M | 1.61M | -319.09K | 116.74K |
| Change in Receivables | 310K | -137K | 303K | 336.89K | -79.89K | -1.09M | 1.32M | -1.1M | -848.33K | 357.67K | 668.43K | -1.45M | 177.17K | -428.4K | 83.38K | -704.25K | -239.15K | 698.68K | 448.45K | -698.51K |
| Change in Inventory | 723K | -1.29M | -322K | -726.2K | -198.8K | 71.46K | 1.16M | -600.44K | -429.87K | -592.86K | -978.06K | -297.26K | 1.75M | 485.92K | 1.05M | 237.87K | -827.35K | -251.5K | -996.44K | -609.79K |
| Change in Payables | 92K | -539K | 193K | 7.28K | -367.28K | 1.36M | -1.13M | -750.29K | -1.28M | 575.88K | 756.63K | -338.81K | 0 | -3.25T | -756.41K | -1.08M | -1.2M | 2.13M | 193.51K | 474.62K |
| Cash from Investing | -46K | -291K | 55K | -131.76K | -47.24K | -124.19K | -298.35K | -118.98K | -127.02K | -135.92K | -257.71K | 140.28K | -682.88K | -206.08K | -716.53K | -4.69M | -847.96K | -1.67M | -1.02M | -984.68K |
| Capital Expenditures | -72K | 32K | -17K | -131.76K | -47.24K | -124.19K | -299K | -118.98K | -127.02K | -135.92K | -257.71K | 140.28K | -682.88K | -206.08K | -716.53K | -4.69M | -847.96K | -1.67M | -1.02M | -984.68K |
| CapEx % of Revenue | 0.81% | 0.35% | 0.18% | 1.37% | 0.54% | 1.36% | 3.47% | 1.35% | 1.41% | 1.85% | 3.32% | 1.49% | 7.23% | 2.19% | 11.09% | 55.15% | 10.7% | 15.51% | 11.43% | 8.66% |
| Acquisitions | 26K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -323K | 72K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 2.48M | 0 | -1.13K | 6.83M | 166.86K | -99.03K | 9.83M | -571.76K | 12.21M | 648.32K | 931.12K | 684.28K | 5M | 0 | 0 | -40.36K | -80.92K | 589.72K | 129.85K |
| Debt Issued (Net) | 0 | 2.48M | 0 | 0 | 0 | -9.36M | -57.58K | 9.98M | -625K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | -5.39M | 0 | -1.13K | 5.39M | 166.86K | -41.46K | 0 | 53.24K | 12.21M | 632.39K | 776.29K | 641.73K | 0 | 0 | 0 | -40.36K | -80.92K | 589.72K | 129.85K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 5.39M | 0 | 0 | 1.44M | 9.36M | 0 | -150K | 0 | 4.97K | 15.93K | 154.83K | 42.55K | 5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -1.44M | -1.29M | -2.67M | -1.38M | 3.35M | -2.41M | -2.77M | -149.67K | -5.52M | 5.77M | -4.79M | -5.9M | -3.1M | -407.67K | -7.61M | -12.86M | -9.11M | -7.22M | -4.57M | -2.86M |
| Free Cash Flow | -1.17M | -4.89M | -2.59M | -1.55M | -3.51M | -2.47M | -2.76M | -4.91M | -4.96M | -6.54M | -5.46M | -6.72M | -3.79M | -5.55M | -7.45M | -12.72M | -8.97M | -7.16M | -5.15M | -3.02M |
| FCF Margin % | -13.23% | -52.93% | -27.35% | -16.09% | -40.24% | -26.95% | -32.04% | -55.58% | -55.14% | -89.04% | -70.47% | -71.37% | -40.12% | -59.06% | -115.3% | -149.78% | -113.16% | -66.45% | -57.86% | -26.58% |
| FCF Growth % | 66.6% | -98.18% | 6% | 68.52% | 29.14% | 62.31% | 49.49% | 26.91% | -30.75% | -17.97% | 26.67% | 47.16% | 57.72% | 22.58% | -44.66% | -321.23% | -203.91% | -441.14% | -39.65% | -309.67% |
| FCF per Share | -0.02 | -0.08 | -0.04 | -0.02 | -0.06 | -0.05 | -0.05 | -0.09 | -0.09 | -0.15 | -0.12 | -0.15 | -0.09 | -0.13 | -0.17 | -0.29 | -0.21 | -0.16 | -0.12 | -0.07 |
| FCF Conversion (FCF/Net Income) | 0.23x | 0.88x | 0.81x | -0.78x | 2.34x | 0.30x | 1.05x | 1.12x | 0.79x | 1.04x | 0.57x | 1.13x | 0.42x | 6.97x | 0.55x | 0.74x | 0.91x | 0.59x | 0.65x | 0.44x |
| Interest Paid | 0 | -1.02M | 517K | 0 | 506.25K | 518.52K | 234.2K | 0 | 0 | 0 | 0 | 0 | 71.11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |